Abiopharma

News list

CLARK KEVIN P 🟢 acquired 243.2K shares of Aptiv PLC (APTV) Transaction Date: Apr 22, 2026 | Filing ID: 173687

Full text

News bot April 23, 2026, 8:08 p.m.
🔍 CLARK KEVIN P (Executive)

Company: Aptiv PLC (APTV)

Report Date: 2026-04-22
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 243,207
- Total shares held: 727,210
Detailed Transactions and Holdings:
- Acquired 97,283 shares of Ordinary Shares (Direct)
  Date: 2026-04-22 | Code: A | equity_swap_involved: false | shares_owned_after: 453,902.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 145,924 shares of Ordinary Shares (Direct)
  Date: 2026-04-22 | Code: A | equity_swap_involved: false | shares_owned_after: 599,826.00 | transaction_form_type: 4 | Footnotes: F3, F2
- Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-04-22 | Code: H | nature_of_ownership: By Kevin P. Clark Revocable Trust | shares_owned_after: 727,210.00
Footnotes:
- F1: The shares will vest in three equal installments beginning on February 28, 2027.
- F2: Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.
- F3: Each performance share represents a contingent right to receive an ordinary share of Aptiv PLC, and will vest based upon the achievement of specified performance criteria, with a performance period from January 1, 2026 to December 31, 2028.